CIPROFLOXACIN 500 MG 10 TAB

21.75 EGP

Each film-coated tablet contains: Ciprofloxacin hydrochloride monohydrate 582 mg Eq to 500 mg Ciprofloxacin.

CIPROFLOXACIN 500 MG 10 TAB; ciprofloxacin, antibacterials .

ACTIVE-INGREDIENT OF CIPROFLOXACIN 500 MG 10 TAB

Each film-coated tablet contains: Ciprofloxacin hydrochloride monohydrate 582 mg Eq to 500 mg Ciprofloxacin.

INDICATION OF CIPROFLOXACIN 500 MG 10 TAB

Ciprofloxacin film-coated tablets are indicated for the treatment of the following infections. Special attention should be paid to available information on resistance to ciprofloxacin before commencing therapy. Consideration should be given to official guidance on the appropriate use of antibacterial agents. Adults: Lower respiratory tract infections due to Gram-negative bacteria. – exacerbations of chronic obstructive pulmonary disease. – broncho-pulmonary infections in cystic fibrosis or in bronchochiectasis. – pneumonia. – Chronic supportive otitis media. – Acute exacerbation of chronic sinusitis especially if theses are caused by Gram-negative bacteria. – Urinary tract infections. – Gonococcal uretritis and cervicitis. – Epididymo-orchitis including cases due to Neisseria gonorrhoeae. – Pelvic inflammatory diseases including cases due to Neisseria gonorrhoeae. In the above genital tract infectons when thought or known to be due to Neisseria gonorrhoeae is is particularly important to obtain local information on the prevalence of resistance to ciprofloxacin and to confirm susceptibility based on laboratory testing. – Infections of the gastro-intestinal tract ( e.g. travellers’ diarrhoea ). – Intra-abdominal infections. – Infections of the skin and soft tissue caused by Gram-negative bacteria. – Malignant external otitis. – Infections of the bones and joints. – Treatment of infections in neutropenic patients. – Prophylaxis of infections in neutropenic patients. – Prophylaxis of invasive infections due to Neisseria meningitidis. – inhalation anthrax (post-exposure prophylaxis and curative treatment). Children and adolescents: – Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa. – Complicated urinary tract infections and pylonephritis. – inhalation anthrax (post-exposure prophylaxis and curative treatment). Ciprofloxacin may also be used to treat severe infections in children and adolescents when this is considered to be necessary. Treatment should be initiayted only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents.

DOSAGE OF CIPROFLOXACIN 500 MG 10 TAB

Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet

Ask your pharmacist or doctor for help if you do not understand the instructions on the box .

The recommended dose is : –

The dosage is determined by the indication, the severity and the site of the infection, the susciptibility to ciprofloxacin of the causative organism(s), the renal function of the patient and, in children and adolescents the body weight. The duration of treatment depends on the severity of the illness and on the clinical and bacteriological course. Treatment of infections due to certain bacteria ( e.g. Pseudomonas aeruginosa, Acinetobacter or Staphylococci ) may require higher ciprofloxacin doses and co-administration with other-appropriate antibacterial agents. Treatment of some infections ( e.g. pelvic inflammatory disease , intra-abdominal infections, infections in neutropenic patients and infections of bones and joints ). may require co-administration with other appropriate antibacterial agents depending on the pathogens involved. In case of infections of the lower respiratory tract : daily dose is 500 mg twice daily to 750 mg twice daily (tab) for 7 to 14 days. In case of infections of the upper respiratory tract (Acute exacerbation of chronic sinusitis): daily dose is 500 mg twice daily to 750 mg twice daily (tab) for 7 to 14 days. In case of infections of the upper respiratory tract (chronic suportive otitis media): daily dose is 500 mg twice daily to 750 mg twice daily (tab) for 7 to 14 days. In case of infections of the upper respiratory tract (Malignant external otitis): daily dose is 750 mg twice daily (tab) for 28 days up to 3 months. In case of urinary tract infections (Uncomplicated cystitis) : daily dose is 250 mg twice daily to 500 mg twice daily for 3 days ( In-premenopausal women, 500 mg single dose may be used. In case of urinary tract infections (complicated cystitis, uncomplicated pyelonephritis) : daily dose is 500 mg twice daily for 7 to 21 days, it can continued for longer than 21 days in some specific circumatances such as abscesses. In case of urinary tract infections (complicated pyelonephritis) : daily dose is 500 mg twice daily to 750 mg twice daily (tab) for at least 10 days, it can continued for longer than 21 days in some specific circumatances such as abscesses. In case of urinary tract infections (prostatitis ) : daily dose is 500 mg twice daily to 750 mg twice daily (tab) for 2 to 4 weeks (acute) to 4 to 6 weeks (chronic). In case of Genital tract infections (Gonococcal uretritis and cercicitis) : daily dose is 500 mg as a single dose for 1 day (single dose). In case of Genital tract infections (Epididymo-orchitis and pelvic inflammatory diseases) : daily dose is 500 mg twice daily to 750 mg twice daily (tab) for at least 14 days. In case of Infections of the gastro-intestinal tract and Intra-abdominal infections ( Diarrhoea caused by bacterial pathogens including Shigella spp. other than Shigella dyseneriae type 1 and emptrical treatment of severe travellers’s diarrhoea) : daily dose is 500 mg twice daily for 1 day. In case of Infections of the gastro-intestinal tract and Intra-abdominal infections ( Diarrhoea caused by Shigella dyseneriae type 1 ) : daily dose is 500 mg twice daily for 5 days. In case of Infections of the gastro-intestinal tract and Intra-abdominal infections ( Diarrhoea caused by Shigella dyseneriae type 1 ) : daily dose is 500 mg twice daily for 5 days. In case of Infections of the gastro-intestinal tract and Intra-abdominal infections ( Diarrhoea caused Vibrio cholerae ) : daily dose is 500 mg twice daily for 3 days. In case of Infections of the gastro-intestinal tract and Intra-abdominal infections ( Typhoid fever ) : daily dose is 500 mg twice daily for 7 days. In case of Infections of the gastro-intestinal tract and Intra-abdominal infections ( Diarrhoea caused Vibrio cholerae ) : daily dose is 500 mg twice daily for 3 days. In case of Infections of the gastro-intestinal tract and Intra-abdominal infections ( Intra-abdominal infections due to Gram-negative bacteria ) : daily dose is 500 mg twice daily to 750 mg twice daily for 5 to 14 days. In case of Infections of the skin and soft tissue : daily dose is 500 mg twice daily to 750 mg twice daily for 7 to 14 days. In case of Bone and joint infections: daily dose is 500 mg twice daily to 750 mg twice daily for max. of 3 months. In case of Treatment of infections or prophylaxis in neutropenic patients Ciprofloxacin should be co-administered with appropriate antibacterial agents in accordance to official guidance: daily dose is 500 mg twice daily to 750 mg twice daily . Therapy should be continued over the entire period of neutropenia. In case of Prophylaxis of invasive infections due to Neisseria meningitides : daily dose is 500 mg as a single dose. for 1 day (single dose). In case of inhalation anthrax (post-exposure prophylaxis and curative treatment for persons able to recieve treatment by oral route when clinically appropriate. Drug administration should begin as soon as possible after suspected or confirmed exposure: daily dose is 500 mg twice daily for 60 days from the confirmation of Bacillus anthracis exposure. Children and adolescents : In case of Cystic fibrosis: daily dose is 20 mg/kg body weight twice daily with a maximum of 750 mg per dose for 10 to 14 days. In case of Complicated urinary tract infections and pylonephritis: daily dose is 10 mg/kg body weight twice daily to 20 mg/kg body weight twice daily with a maximum of 750 mg per dose for 10 to 21 days. In case of inhalation anthrax (post-exposure prophylaxis and curative treatment for persons able to recieve treatment by oral route when clinically appropriate. Drug administration should begin as soon as possible after suspected or confirmed exposure: daily dose is 10 mg/kg body weight twice daily to 15 mg/kg body weight twice daily with a maximum of 500 mg per dose for 60 days from the confirmation of Bacillus anthracis exposure. In case of other severe infections: 20 mg/kg body weight twice daily with a maximum of 750 mg per dose Total duration According to the type of infections. Geriatric patients: Geriatric patients should recieve a dose selected according to the severity of the infectioin and the patient’s creatinine clearance. Renal and hepatic impairment: Recommended starting and maintenance doses for patients with impaired renal function: In case of (creatinine clearance > 60 ml/min/1.73 m2): serum creatinine 169 µmol/L : Dose is 250-500 mg every 24 h (after dialysis). In case of patients on haemodialysis : serum creatinine > 169 µmol/L : Dose is 250-500 mg every 24 h (after dialysis) . In case of patients on peritoneal dialysis : serum creatinine > 169 µmol/L : Dose is 250-500 mg every 24 h . In patients with impaired liver function no dose adjustment is required. Dosing in children with impaired renal and/or hepatic function has not been studied. Method of administration: Tablets are not swallowed unchewed with fluid. They can be taken independent of mealtimes. If taken on an empty stomach, the active substance is absorbed more rapidly. Ciprofloxacin tablets should not be taken with dairy products ( e.g. milk, yoghurt) or mineral-fortified fruit-juice ( e.g. calcium-fortified orange juice). In severe cases or if the patient is unable to take tablets ( e.g. patients on enteral nutrition), it is recommended to commence therapy with intravenous ciprofloxacin until a switch to oral administration is possible.

OVER-DOSAGE OF CIPROFLOXACIN 500 MG 10 TAB

An overdose of 12 g has been reported to lead to mild symptoms of toxicity. An acute overdose of 16 g has been reported to cause acute renal failure. Symptoms in overdose consist of dizziness, tremor, headache, tiredness, seizures,hallucinations, confusion, abdominal discomfort, renal and hepatic impairment as well as crytalluria and haematuria. Reversible renal toxicity has been reported. Apart from routine emergency measures. It is recommended to monitor renal function, including urinary pH and acidify, if required, to prevent crystalluria. Patients should be kept well hydrated. Only small of ciprofloxacin (CONTRA-INDICATION OF CIPROFLOXACIN 500 MG 10 TAB

Hypersensitivity to the active substance, to other quinolones or to any of the excipients. Concomitant administration of ciprofloxacin and tizanidine.

STORAGE OF CIPROFLOXACIN 500 MG 10 TAB

Store in a dry place at room temperature not exceeding 30 °C. Keep out of reach of children.
PACK OF CIPROFLOXACIN 500 MG 10 TAB
Carton box contain one (Al/PVC) strip of 10 tablets. With inner leaflet.
CIPROFLOXACIN 500 MG 10 TAB MANUFACTURED BY
ORGANO FOR PHARMACEUTICAL & CHEMICAL INDUSTRIES. (ORGANOPHARMA)

https://www.drugs.com/ciprofloxacin.html

https://www.gardeniapharmacy.com/category/medicine-2/

Form

Gender

How to use

Reviews

There are no reviews yet.

Show reviews in all languages (1)

Be the first to review “CIPROFLOXACIN 500 MG 10 TAB”

Your email address will not be published. Required fields are marked *

Shopping Cart
Don`t copy text!
Scroll to Top
Open chat